• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Wave, with new data, plots path forward for Huntington’s drug

cafead

Administrator
Staff member
  • cafead   Jun 25, 2024 at 09:22: PM
via Study results showed the company’s antisense medicine lowered levels of the mutant protein linked to the disease, while sparing a “wild-type” form that’s thought to play a helpful role.

article source